169 related articles for article (PubMed ID: 29621029)
1. Trimethoprim-sulfamethoxazole and antineutrophil cytoplasmic antibodies-associated vasculitis.
Cohen Tervaert JW
Curr Opin Rheumatol; 2018 Jul; 30(4):388-394. PubMed ID: 29621029
[TBL] [Abstract][Full Text] [Related]
2. No evident association of nasal carriage of Staphylococcus aureus or its small-colony variants with cotrimoxazole use or ANCA-associated vasculitis relapses.
Tan BK; Crabol Y; Tasse J; Laurent F; Nekkab N; Vinter C; Puéchal X; Guillevin L
Rheumatology (Oxford); 2020 Jan; 59(1):77-83. PubMed ID: 31834404
[TBL] [Abstract][Full Text] [Related]
3. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate.
Salmela A; Rasmussen N; Tervaert JWC; Jayne DRW; Ekstrand A;
Rheumatology (Oxford); 2017 Jun; 56(6):965-972. PubMed ID: 28339745
[TBL] [Abstract][Full Text] [Related]
4. A case of probable trimethoprim-sulfamethoxazole induced circulating antineutrophil cytoplasmic antibody-positive small vessel vasculitis.
Woodring T; Abraham R; Frisch S
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469750
[TBL] [Abstract][Full Text] [Related]
5. Rituximab resistance at 3months of induction therapy in newly diagnosed or relapsing ANCA-associated vasculitis: A French multicentre retrospective study in 116 patients.
Machet T; Quémeneur T; Ledoult E; Mesbah R; Lebas C; Hachulla E; Pokeerbux MR
Joint Bone Spine; 2023 Sep; 90(5):105591. PubMed ID: 37230162
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis.
Kronbichler A; Kerschbaum J; Gopaluni S; Tieu J; Alberici F; Jones RB; Smith RM; Jayne DRW
Ann Rheum Dis; 2018 Oct; 77(10):1440-1447. PubMed ID: 29950327
[TBL] [Abstract][Full Text] [Related]
7. Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?
Tesar V; Hruskova Z
Expert Opin Pharmacother; 2015; 16(11):1683-702. PubMed ID: 26149512
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-sulfamethoxazole prophylaxis during treatment of granulomatosis with polyangiitis with rituximab in the United States of America: a retrospective cohort study.
Mendel A; Behlouli H; de Moura CS; Vinet É; Curtis JR; Bernatsky S
Arthritis Res Ther; 2023 Jul; 25(1):133. PubMed ID: 37516897
[TBL] [Abstract][Full Text] [Related]
10. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
12. Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab.
Cartin-Ceba R; Fervenza FC; Specks U
Curr Opin Rheumatol; 2012 Jan; 24(1):15-23. PubMed ID: 22089095
[TBL] [Abstract][Full Text] [Related]
13. [Should patients with ANCA-associated vasculitis undergoing maintenance therapy with rituximab receive cotrimoxazole prophylaxis?].
Mahrhofer H
Z Rheumatol; 2024 Mar; 83(2):122-124. PubMed ID: 38272971
[No Abstract] [Full Text] [Related]
14. Granulomatosis with polyangiitis in Tunisia.
Ben Ghorbel I; Belfeki N; Baouendi N; Ben Salem T; Houman MH
Reumatismo; 2017 May; 69(1):23-29. PubMed ID: 28535618
[TBL] [Abstract][Full Text] [Related]
15. The role of trimethoprim/sulfametoxazole in reducing relapses and risk of infections in ANCA-associated vasculitis: a meta-analysis.
Monti S; Delvino P; Riboli M; Rebuffi C; Xoxi B; De Silvestri A; Montecucco C
Rheumatology (Oxford); 2021 Aug; 60(8):3553-3564. PubMed ID: 33752235
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis.
Smith RM; Jones RB; Guerry MJ; Laurino S; Catapano F; Chaudhry A; Smith KG; Jayne DR
Arthritis Rheum; 2012 Nov; 64(11):3760-9. PubMed ID: 22729997
[TBL] [Abstract][Full Text] [Related]
17. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
18. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3.
Relle M; Föhr B; Fasola F; Schwarting A
Mol Cell Probes; 2016 Dec; 30(6):366-373. PubMed ID: 27559009
[TBL] [Abstract][Full Text] [Related]
19. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis.
McGregor JG; Hogan SL; Kotzen ES; Poulton CJ; Hu Y; Negrete-Lopez R; Kidd JM; Katsanos SL; Bunch DO; Nachman PH; Falk RJ
Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1(Suppl 1):i123-31. PubMed ID: 25805743
[TBL] [Abstract][Full Text] [Related]
20. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
